• What is Curator?
  • Your Feedback

The Curator finds, summarizes, and links to the highest-quality, most authoritative online sources of business and political news and information: breaking news, analysis, background and opinion. Learn more »

Have something you'd like to share?

Is there an important story you think we should cover or features you would like added? Let us know »

Topics

2008 U.S. Presidential Election  American International Group  Bailout  Bankruptcy  Barack Obama  China  Commercial Banking  Credit Crisis  Economic News  Federal Reserve  Financial Crisis  Financial Services  George W. Bush  Google  Information Technology  Insurance  John McCain  Lehman Brothers  Markets, Economic News  Mergers & Acquisitions  Mergers and Acquisitions  Microsoft  Mortgage Crisis  National Elections  Oil  Russia  SAAS  Sarah Palin  U.S. Treasury  iPhone 

October 7, 2008 · 3:31AM

Dendreon Prostate Cancer Study Appears Promising

Dendreon prostate cancer vaccine Provenge cut the risk of death in a test by 20% compared with a placebo. The study is not yet complete; the biotech’s goal is a 22% reduction in the risk of death. (WSJ)

Categories: Biotech, Pharma · Business & Finance Today · Healthcare

Bookmark and share

del.icio.us Digg Furl Facebook Google Newsvine Propeller StumbleUpon Technorati Twitter Windows Live YahooMyWeb

No Comments Yet

You can be the first to comment!

Leave a comment

Previous | Next
Permalink | Trackback